Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Broncus Holding Corp. ( (HK:2216) ) just unveiled an announcement.
Broncus Holding Corp. announced a proposed issue of shares under a general mandate, agreeing to allot and issue 105,108,015 subscription shares at HK$3.11 per share. This move, representing approximately 19.90% of the company’s issued share capital, is expected to raise gross proceeds of HK$326.9 million, which will support the company’s expansion in the medical devices industry. The completion of the subscription agreements is subject to certain conditions, and stakeholders are advised to exercise caution.
The most recent analyst rating on (HK:2216) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Broncus Holding Corp. stock, see the HK:2216 Stock Forecast page.
More about Broncus Holding Corp.
Broncus Holding Corp. is a company incorporated in the Cayman Islands, primarily focused on the medical devices industry. It is involved in expanding its product portfolio through potential acquisitions, indicating a strategic focus on growth within the healthcare sector.
Average Trading Volume: 3,927,575
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.73B
For a thorough assessment of 2216 stock, go to TipRanks’ Stock Analysis page.